Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Baroda BNP Paribas Business Cycle Fund · Direct ✕HDFC Pharma and Healthcare Fund · Direct ✕

Growth of ₹10,000

Basics

Baroda BNP Paribas Business Cycle FundHDFC Pharma and Healthcare Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseBaroda BNPHDFC
NAV₹18.0677₹23.6750
NAV date20 Nov 202620 Nov 2026
History5.2 years3.1 years
Expense ratio1.1%1.1%
Stars★★★★★★★★★★
Growth Score48.0094.50

Returns

Baroda BNP Paribas Business Cycle FundHDFC Pharma and Healthcare Fund
1 month+9.18%+12.97%
3 months+3.13%+7.13%
6 months+8.62%+17.84%
YTD+5.48%+33.73%
1 year+5.68%+32.20%
3 years (CAGR)+13.61%+30.70%
5 years (CAGR)+12.45%—
10 years (CAGR)——
Since launch+12.09%+31.83%

Risk

Baroda BNP Paribas Business Cycle FundHDFC Pharma and Healthcare Fund
Volatility16.4%15.8%
Downside volatility11.0%8.5%
Sharpe0.431.53
Sortino0.652.86
Calmar0.672.06
Return / risk0.831.95
Deepest fall−20.27%−14.91%
Days to recover621126
Below its high+0.00%+0.00%

Against benchmark

Baroda BNP Paribas Business Cycle FundHDFC Pharma and Healthcare Fund
Alpha+1.67%+7.54%
Beta1.000.97
R²96.0%85.0%
Up capture107.1%108.9%
Down capture101.3%71.0%
Tracking error3.3%6.1%
Information ratio0.501.17
Treynor0.060.24

Consistency

Baroda BNP Paribas Business Cycle FundHDFC Pharma and Healthcare Fund
Best 1-year+51.92%+67.01%
Middle 1-year+7.52%+23.25%
Worst 1-year−9.50%+1.71%
1-year periods with a loss14.8%0.0%
Middle 3-year+17.11%+30.22%
Positive months63.9%72.2%
Best day+3.55%+3.18%
Worst day−6.39%−3.61%
Worst 5% day−1.42%−1.51%
Positive days56.4%58.3%
NAVs a year247247

SIP of ₹10,000 a month

Baroda BNP Paribas Business Cycle FundHDFC Pharma and Healthcare Fund
5-year XIRR+12.89%—
5-year value₹8,34,504—
3-year XIRR+8.40%+27.71%
1-year XIRR+13.44%+41.37%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth